Vik Arora

Vik Arora, Ph.D., DABT, currently serves as the VP of Toxicology at Voyager Therapeutics, Inc., a position held since September 2023. Prior roles include VP of Nonclinical Development at Opus Genetics, and various senior director positions at Grifols, focusing on Global Product Safety and Research & Preclinical Development. Vik Arora has also held the role of Director of Toxicology at Talecris Biotherapeutics and was a Principal Research Scientist at Bayer Pharmaceuticals. Early career experience includes serving as Group Leader at AVI BioPharma Inc. Educational credentials include a Ph.D. in Pharmacology & Toxicology from the University of Nebraska Medical Center and Bachelor’s degrees in Human Biology from the All India Institute of Medical Sciences.